Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
BioBridge Global is a San Antonio-based non-profit healthcare services organization that provides an integrated suite of services supporting the development and delivery of advanced therapies. The organization operates through specialized subsidiaries, including South Texas Blood & Tissue, QualTex Laboratories, and the recently launched BBG Advanced Therapies, to offer a 'donor-to-patient' continuum of products and expertise. Its core capabilities span blood resource management, cGMP-compliant biomanufacturing, and specialized testing for cell and gene therapy developers. BioBridge Global serves as a critical partner for the life sciences industry by providing high-quality human starting materials, such as leukopaks and cord blood, while supporting process development and clinical research. The group also collaborates extensively with academic, military, and commercial institutions to advance regenerative medicine. Through its comprehensive infrastructure, the company aims to simplify the pathway from therapy discovery to commercial scale-up.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on BioBridge Global.